REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Gratia Husada Farma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Gratia Husada Farma Profile Updated: November 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

PT Gratia Husada Farma is a company based in Indonesia, with its head office in Ungaran. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on March 30, 1974. The latest financial highlights indicate a net sales revenue increase of 19.74% in 2025. A growth of 23.78% was recorded in its total assets.

Headquarters
Kawasan Industri Candi Blok V No 11
Ungaran; Central Java; Postal Code: 50184

Contact Details: Purchase the PT Gratia Husada Farma report to view the information.

Website: http://www.hufa.co.id

Basic Information
Registered Capital:
Purchase the PT Gratia Husada Farma report to view the information.
Financial Auditors:
Purchase the PT Gratia Husada Farma report to view the information.
Incorporation Date:
March 30, 1974
Key Executives
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Gratia Husada Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
19.74%
Total Operating Revenue
19.74%
Total Assets
23.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?